Page last updated: 2024-10-21

5,5-dimethyl-1-pyrroline-1-oxide and Cardiomyopathies

5,5-dimethyl-1-pyrroline-1-oxide has been researched along with Cardiomyopathies in 1 studies

5,5-dimethyl-1-pyrroline-1-oxide: do not confuse with DMPO (4',5'-dihydroxy-7-methoxy-4-phenyl-5,2'-oxidocoumarin)
5,5-dimethyl-1-pyrroline N-oxide : A member of the class of 1-pyrroline nitrones (1-pyrroline N-oxides) resulting from the formal N-oxidation of 5,5-dimethyl-1-pyrroline. Used as a spin trap for the study of radicals formed by enzymatic acetaldehyde oxidation.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Monti, E1
Paracchini, L1
Perletti, G1
Piccinini, F1

Other Studies

1 other study available for 5,5-dimethyl-1-pyrroline-1-oxide and Cardiomyopathies

ArticleYear
Protective effects of spin-trapping agents on adriamycin-induced cardiotoxicity in isolated rat atria.
    Free radical research communications, 1991, Volume: 14, Issue:1

    Topics: Animals; Cardiomyopathies; Cyclic N-Oxides; Depression, Chemical; Doxorubicin; Female; Free Radicals

1991